A study of maternal and perinatal outcome in cases of HELLP and partial HELLP syndrome

Kanchan Durugkar


Background: The HELLP syndrome is a serious complication in pregnancy characterized by haemolysis, elevated liver enzymes and low platelet count occurring in 0.5 to 0.9% of all pregnancies and in 10-20% of cases with severe preeclampsia. The objective of the present prospective study is to study on incidence, diagnosis, and variable presentations of HELLP syndrome in preeclampsia to analyse the severity and complications, as it is associated with maternal, perinatal morbidity and mortality. HELLP syndrome is difficult to diagnose when it presents with atypical clinical features.

Methods: In the prospective study of 300 admitted cases with more than 20 weeks of gestation, were having preeclampsia. The selected cases were analyzed clinically with relevant history, clinical data and detailed laboratory investigations made for better analyses of complications and outcome in HELLP syndrome.

Results: Under further clinical diagnosis of 300 cases of preeclampsia, 34 cases (11.33%) were of HELLP Syndrome and 44 (14.66%) cases were of partial HELLP syndrome. The present study shows 2.9% maternal mortality in HELLP and 4.5% in partial HELLP syndrome. Perinatal mortality was 17.6% with HELLP and 25% with partial HELLP.

Conclusions: The diagnosis of HELLP syndrome has been made as a severe variant and complication of severe preeclampsia and eclampsia. It needs early diagnosis, timely intervention to arrest further progress and complications like multi organ dysfunction, renal failure, DIC, abruption etc and to improve maternal and perinatal outcome.


HELLP syndrome, Maternal morbidity, Perinatal mortality

Full Text:



Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management: a review. BMC Pregnancy Childbirth. 2009;9:8.

Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol.1996;175:460-4.

Martin JN, Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol. 2006;195:914-34.

Abramovici D, Friedman SA, Mercer BM, Audibert F, Kao L,Sibai BM. Neonatal outcome in severe preeclampsia at 24 to 36weeks’ gestation: Does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol. 1999;180:221-5.

Barton JR, Sibai BM. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol. 2004;31:807-33.

Pritchard JA, Cunningham FG, Masan RA. Coagulation changes in eclampsia; their frequency and pathogenesis. Am J Obst Gynaecol. 1976;124:855.

Abbade JF, Peraçoli JC, Costa RA, Calderon ID, Borges VT, Rudge MV. Partial HELLP syndrome: maternal and perinatal outcome. Sao Paulo Med J. 2002;120(6):180-4.

Chhabra S, Qureshi A, Datta N. Perinatal outcome with HELLP/partial HELLP complicating hypertensive disorders of pregnancy: an Indian rural experience. J Obstet Gynaecol. 2006;26(6):531-3.

Tandon A, Chaudhari P, Gupta V, Ramola M. Feto-maternal outcome in HELLP and partial HELLP syndrome. Int J Reprod Contracept Obstet Gynecol. 2016;5(9):3066-71.

Ahmed FA, Amin A, Naeem NK. HELLP syndrome, a clinical variant of pre-eclampsia. Annals. 2007;13(2):158.

Kumru S, Güretaş MSB, Sapmaz E, Aygün D. Comparison of maternal and perinatal outcomes of HELLP syndrome and severe preeclampsia cases. Perinatal J. 2005;13(1):9-14.

Banoo S, Makhdoomi TA, Mir S, Malik J. Incidence of HELLP syndrome and its effect on maternal and perinatal outcome. JK Practitioner. 2007;14(2):92-4.

Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993;169:1000-06.

Aarnoudse JG, Houthoff HJ, Weits J, Vellenga E, Huisjes HJ. A syndrome of liver damage and intravascular coagulation in the last trimester of normotensive pregnancy. A clinical and histopathological study. Br J Obstet Gynaecol. 1986;93:145-55.

Minakami H, Oka N, Sato T, Tamada T, Yasuda Y, Hirota N. Preeclampsia: a microvesicular fat disease of the liver?. Am J Obstet Gynecol. 159:1043-7.

Beller FK, Dame WR, Ebert C. Pregnancy induced hypertension complicated by thrombocytopenia hemolysis and elevated liver enzymes (HELLP) syndrome: renal biopsies and outcome. Au Nz J Obst Gynecol. 1985;25:83.

Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obst Gynecol. 1382;142:159

Gul A, Cebeci A, Aslan H, Polat I, Ozdemir A, Ceylan Y. Perinatal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome. Gynecol Obstet Invest. 2005;59:113-8.

Hadded B, Barton JR, Livingston JC, Chahine R, Sibai BM. Risk factors for adverse maternal outcome among women with HELLP syndrome. Am J Obstet Gynecol. 2000;183:444-8.